Skip to main content
Top
Published in: Current Treatment Options in Cardiovascular Medicine 10/2019

01-10-2019 | Heart Failure | Heart Failure (W Tang, Section Editor)

The Impact of Pharmacist-Based Services Across the Spectrum of Outpatient Heart Failure Therapy

Authors: Lucianne M. West, PharmD, BCCP, J. Bradley Williams, PharmD, BCPS, Kathleen D. Faulkenberg, PharmD, BCPS

Published in: Current Treatment Options in Cardiovascular Medicine | Issue 10/2019

Login to get access

Abstract

Purpose of review

A multidisciplinary approach is vital to reduce mortality and hospitalizations in patients with heart failure. As members of the multidisciplinary team, pharmacists are uniquely positioned to care for patients across the spectrum of heart failure. This comprehensive review explores the different facets in which pharmacists can be utilized to impact the care for patients with heart failure, including those with cardiac transplant and left ventricular assist devices (LVADs), in the outpatient setting.

Recent findings

Pharmacists can see heart failure patients in a variety of settings to reduce drug therapy–related issues, increase use of guideline-directed medical therapy (GDMT), and reduce hospitalizations. Although there is limited data available, pharmacists have also been described in aiding the therapeutic drug monitoring of warfarin for patients with LVADs and immunosuppression agents in the transplant population.

Summary

Through collaborative practice agreements, pharmacists can provide progressive services such as titration of GDMT and lab monitoring, in addition to medication reconciliation, education, and review for potential drug-related problems. Pharmacists can increase access to patient care by providing services through distance-visits, shared medical appointments, and home visits.
Literature
1.
go back to reference Mozaffarian. Heart Disease and stroke statistics-2016 update: a report from the American Heart Association (vol 133, pg e38, 2016). Circulation. 2016;133(15):E599. Mozaffarian. Heart Disease and stroke statistics-2016 update: a report from the American Heart Association (vol 133, pg e38, 2016). Circulation. 2016;133(15):E599.
2.
go back to reference Page RL. Drugs that may cause or exacerbate heart failure: a scientific statement from the American Heart Association (vol 134, pg e32, 2016). Circulation. 2016;134(12):E261. Page RL. Drugs that may cause or exacerbate heart failure: a scientific statement from the American Heart Association (vol 134, pg e32, 2016). Circulation. 2016;134(12):E261.
3.
go back to reference Yancy CW, et al. ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013;62(16):e147–239.PubMed Yancy CW, et al. ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013;62(16):e147–239.PubMed
4.
go back to reference •• Milfred-Laforest SK, et al. Clinical pharmacy services in heart failure: an opinion paper from the Heart Failure Society of America and American College of Clinical Pharmacy Cardiology Practice and Research Network. J Card Fail. 2013;19(5):354–69. First opinion paper describing the benefits of clinical pharmacy services in patients with heart failure.PubMed •• Milfred-Laforest SK, et al. Clinical pharmacy services in heart failure: an opinion paper from the Heart Failure Society of America and American College of Clinical Pharmacy Cardiology Practice and Research Network. J Card Fail. 2013;19(5):354–69. First opinion paper describing the benefits of clinical pharmacy services in patients with heart failure.PubMed
5.
go back to reference •• Dunn SP, et al. The role of the clinical pharmacist in the care of patients with cardiovascular disease. J Am Coll Cardiol. 2015;66(19):2129–39. Describes the training and qualifications of clinical pharmacist to provide care for patients with cardiovascular diseases. Provides a systematic review of summarizing pharmacy services provided to patients with cardiovascular disease.PubMed •• Dunn SP, et al. The role of the clinical pharmacist in the care of patients with cardiovascular disease. J Am Coll Cardiol. 2015;66(19):2129–39. Describes the training and qualifications of clinical pharmacist to provide care for patients with cardiovascular diseases. Provides a systematic review of summarizing pharmacy services provided to patients with cardiovascular disease.PubMed
6.
go back to reference Lenander C, Elfsson B, Danielsson B, Midlöv P, Hasselström J. Effects of a pharmacist-led structured medication review in primary care on drug-related problems and hospital admission rates: a randomized controlled trial. Scand J Prim Health Care. 2014;32(4):180–6.PubMedPubMedCentral Lenander C, Elfsson B, Danielsson B, Midlöv P, Hasselström J. Effects of a pharmacist-led structured medication review in primary care on drug-related problems and hospital admission rates: a randomized controlled trial. Scand J Prim Health Care. 2014;32(4):180–6.PubMedPubMedCentral
7.
go back to reference Masoudi FA, Baillie CA, Wang Y, Bradford WD, Steiner JF, Havranek EP, et al. The complexity and cost of drug regimens of older patients hospitalized with heart failure in the United States, 1998-2001. Arch Intern Med. 2005;165(18):2069–76.PubMed Masoudi FA, Baillie CA, Wang Y, Bradford WD, Steiner JF, Havranek EP, et al. The complexity and cost of drug regimens of older patients hospitalized with heart failure in the United States, 1998-2001. Arch Intern Med. 2005;165(18):2069–76.PubMed
8.
go back to reference Dempsey JT, Matta LS, Carter DM, Stevens CA, Stevenson LW, Desai AS, et al. Assessment of drug therapy-related issues in an outpatient heart failure population and the potential impact of pharmacist-driven intervention. J Pharm Pract. 2017;30(3):318–23.PubMed Dempsey JT, Matta LS, Carter DM, Stevens CA, Stevenson LW, Desai AS, et al. Assessment of drug therapy-related issues in an outpatient heart failure population and the potential impact of pharmacist-driven intervention. J Pharm Pract. 2017;30(3):318–23.PubMed
9.
go back to reference Gastelurrutia P, Benrimoj SI, Espejo J, Tuneu L, Mangues MA, Bayes-Genis A. Negative clinical outcomes associated with drug-related problems in heart failure (HF) outpatients: impact of a pharmacist in a multidisciplinary HF clinic. J Card Fail. 2011;17(3):217–23.PubMed Gastelurrutia P, Benrimoj SI, Espejo J, Tuneu L, Mangues MA, Bayes-Genis A. Negative clinical outcomes associated with drug-related problems in heart failure (HF) outpatients: impact of a pharmacist in a multidisciplinary HF clinic. J Card Fail. 2011;17(3):217–23.PubMed
10.
go back to reference Yates L, Valente, M, Wadsworth C. Evaluation of pharmacist medication review service in an outpatient Heart Failure Clinic. J Pharm Pract. 2019;897190019842696. Yates L, Valente, M, Wadsworth C. Evaluation of pharmacist medication review service in an outpatient Heart Failure Clinic. J Pharm Pract. 2019;897190019842696.
11.
go back to reference Murray MD, Young J, Hoke S, Tu W, Weiner M, Morrow D, et al. Pharmacist intervention to improve medication adherence in heart failure: a randomized trial. Ann Intern Med. 2007;146(10):714–25.PubMed Murray MD, Young J, Hoke S, Tu W, Weiner M, Morrow D, et al. Pharmacist intervention to improve medication adherence in heart failure: a randomized trial. Ann Intern Med. 2007;146(10):714–25.PubMed
12.
go back to reference Varma S, McElnay JC, Hughes CM, Passmore AP, Varma M. Pharmaceutical care of patients with congestive heart failure: interventions and outcomes. Pharmacotherapy. 1999;19(7):860–9.PubMed Varma S, McElnay JC, Hughes CM, Passmore AP, Varma M. Pharmaceutical care of patients with congestive heart failure: interventions and outcomes. Pharmacotherapy. 1999;19(7):860–9.PubMed
13.
go back to reference Bucci C, et al. Pharmacist’s contribution in a heart function clinic: patient perception and medication appropriateness. Can J Cardiol. 2003;19(4):391–6.PubMed Bucci C, et al. Pharmacist’s contribution in a heart function clinic: patient perception and medication appropriateness. Can J Cardiol. 2003;19(4):391–6.PubMed
14.
go back to reference Dempsey J, Gillis C, Sibicky S, Matta L, MacRae C, Kirshenbaum J, et al. Evaluation of a transitional care pharmacist intervention in a high-risk cardiovascular patient population. Am J Health Syst Pharm. 2018;75(17 Supplement 3):S63–71.PubMed Dempsey J, Gillis C, Sibicky S, Matta L, MacRae C, Kirshenbaum J, et al. Evaluation of a transitional care pharmacist intervention in a high-risk cardiovascular patient population. Am J Health Syst Pharm. 2018;75(17 Supplement 3):S63–71.PubMed
15.
go back to reference Singh-Franco D, Li L, Hannah S, Diamond M. Role of clinical pharmacist in a heart failure clinic. Hosp Pharm. 2005;40(10):890–6. Singh-Franco D, Li L, Hannah S, Diamond M. Role of clinical pharmacist in a heart failure clinic. Hosp Pharm. 2005;40(10):890–6.
16.
go back to reference Elman S, Zaiken K. Improving performance of an accountable care organization on a quality measure assessing beta-blocker use in systolic heart failure. Am J Health Syst Pharm. 2016;73(17 Suppl 4):S121–5.PubMed Elman S, Zaiken K. Improving performance of an accountable care organization on a quality measure assessing beta-blocker use in systolic heart failure. Am J Health Syst Pharm. 2016;73(17 Suppl 4):S121–5.PubMed
17.
go back to reference Bouvy ML, Heerdink ER, Urquhart J, Grobbee DE, Hoes AW, Leufkens HG. Effect of a pharmacist-led intervention on diuretic compliance in heart failure patients: a randomized controlled study. J Card Fail. 2003;9(5):404–11.PubMed Bouvy ML, Heerdink ER, Urquhart J, Grobbee DE, Hoes AW, Leufkens HG. Effect of a pharmacist-led intervention on diuretic compliance in heart failure patients: a randomized controlled study. J Card Fail. 2003;9(5):404–11.PubMed
18.
go back to reference Turner CJ, Parfrey P, Ryan K, Miller R, Brown A. Community pharmacist outreach program directed at physicians treating congestive heart failure. Am J Health Syst Pharm. 2000;57(8):747–52.PubMed Turner CJ, Parfrey P, Ryan K, Miller R, Brown A. Community pharmacist outreach program directed at physicians treating congestive heart failure. Am J Health Syst Pharm. 2000;57(8):747–52.PubMed
19.
go back to reference Ziman ME, Bui HT, Smith CS, Tsukiji LA, Asmatey VM, Chu SB, et al. The pharmacists’ role in improving guideline compliance for thyroid function testing in patients with heart failure. J Pharm Pract. 2012;25(2):195–200.PubMed Ziman ME, Bui HT, Smith CS, Tsukiji LA, Asmatey VM, Chu SB, et al. The pharmacists’ role in improving guideline compliance for thyroid function testing in patients with heart failure. J Pharm Pract. 2012;25(2):195–200.PubMed
20.
go back to reference Bleske BE, Dillman NO, Cornelius D, Ward JK, Burson SC, Diez HL, et al. Heart failure assessment at the community pharmacy level: a feasibility pilot study. J Am Pharm Assoc (2003). 2014;54(6):634–41. Bleske BE, Dillman NO, Cornelius D, Ward JK, Burson SC, Diez HL, et al. Heart failure assessment at the community pharmacy level: a feasibility pilot study. J Am Pharm Assoc (2003). 2014;54(6):634–41.
21.
go back to reference Lowrie R, Johansson L, Forsyth P, Bryce SL, McKellar S, Fitzgerald N. Experiences of a community pharmacy service to support adherence and self-management in chronic heart failure. Int J Clin Pharm. 2014;36(1):154–62.PubMed Lowrie R, Johansson L, Forsyth P, Bryce SL, McKellar S, Fitzgerald N. Experiences of a community pharmacy service to support adherence and self-management in chronic heart failure. Int J Clin Pharm. 2014;36(1):154–62.PubMed
22.
go back to reference Laufs U, Griese-Mammen N, Krueger K, Wachter A, Anker SD, Koehler F, et al. PHARMacy-based interdisciplinary program for patients with Chronic Heart Failure (PHARM-CHF): rationale and design of a randomized controlled trial, and results of the pilot study. Eur J Heart Fail. 2018;20(9):1350–9.PubMed Laufs U, Griese-Mammen N, Krueger K, Wachter A, Anker SD, Koehler F, et al. PHARMacy-based interdisciplinary program for patients with Chronic Heart Failure (PHARM-CHF): rationale and design of a randomized controlled trial, and results of the pilot study. Eur J Heart Fail. 2018;20(9):1350–9.PubMed
23.
go back to reference • Schulz M, Griese-Mammen N, Anker SD, Koehler F, Ihle P, Ruckes C, et al. Pharmacy-based interdisciplinary intervention for patients with chronic heart failure: results of the PHARM-CHF randomized controlled trial. Eur J Heart Fail. 2019Recent large randomized control trial demonstrating the positive impact of pharmacist in the community setting on medication adherence. • Schulz M, Griese-Mammen N, Anker SD, Koehler F, Ihle P, Ruckes C, et al. Pharmacy-based interdisciplinary intervention for patients with chronic heart failure: results of the PHARM-CHF randomized controlled trial. Eur J Heart Fail. 2019Recent large randomized control trial demonstrating the positive impact of pharmacist in the community setting on medication adherence.
24.
go back to reference Yancy CW, et al. ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines and the Heart Failure Society of America. J Am Coll Cardiol. 2017;70(6):776–803.PubMed Yancy CW, et al. ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines and the Heart Failure Society of America. J Am Coll Cardiol. 2017;70(6):776–803.PubMed
25.
go back to reference Fonarow GC, Abraham WT, Albert NM, Stough WG, Gheorghiade M, Greenberg BH, et al. Dosing of beta-blocker therapy before, during, and after hospitalization for heart failure (from organized program to initiate lifesaving treatment in hospitalized patients with heart failure). Am J Cardiol. 2008;102(11):1524–9.PubMed Fonarow GC, Abraham WT, Albert NM, Stough WG, Gheorghiade M, Greenberg BH, et al. Dosing of beta-blocker therapy before, during, and after hospitalization for heart failure (from organized program to initiate lifesaving treatment in hospitalized patients with heart failure). Am J Cardiol. 2008;102(11):1524–9.PubMed
26.
go back to reference Fonarow GC, Yancy CW, Hernandez AF, Peterson ED, Spertus JA, Heidenreich PA. Potential impact of optimal implementation of evidence-based heart failure therapies on mortality. Am Heart J. 2011;161(6):1024–30 e3.PubMed Fonarow GC, Yancy CW, Hernandez AF, Peterson ED, Spertus JA, Heidenreich PA. Potential impact of optimal implementation of evidence-based heart failure therapies on mortality. Am Heart J. 2011;161(6):1024–30 e3.PubMed
27.
go back to reference Greene SJ, Butler J, Albert NM, DeVore AD, Sharma PP, Duffy CI, et al. Medical therapy for heart failure with reduced ejection fraction: the CHAMP-HF registry. J Am Coll Cardiol. 2018;72(4):351–66.PubMed Greene SJ, Butler J, Albert NM, DeVore AD, Sharma PP, Duffy CI, et al. Medical therapy for heart failure with reduced ejection fraction: the CHAMP-HF registry. J Am Coll Cardiol. 2018;72(4):351–66.PubMed
28.
go back to reference Peri-Okonny PA, Mi X, Khariton Y, Patel KK, Thomas L, Fonarow GC, et al. Target doses of heart failure medical therapy and blood pressure: insights from the CHAMP-HF registry. JACC Heart Fail. 2019;7(4):350–8.PubMed Peri-Okonny PA, Mi X, Khariton Y, Patel KK, Thomas L, Fonarow GC, et al. Target doses of heart failure medical therapy and blood pressure: insights from the CHAMP-HF registry. JACC Heart Fail. 2019;7(4):350–8.PubMed
29.
go back to reference Gattis WA, Hasselblad V, Whellan DJ, O'Connor CM. Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team: results of the Pharmacist in Heart Failure Assessment Recommendation and Monitoring (PHARM) Study. Arch Intern Med. 1999;159(16):1939–45.PubMed Gattis WA, Hasselblad V, Whellan DJ, O'Connor CM. Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team: results of the Pharmacist in Heart Failure Assessment Recommendation and Monitoring (PHARM) Study. Arch Intern Med. 1999;159(16):1939–45.PubMed
30.
go back to reference Al-Bawardy R, et al. Heart failure postdischarge clinic: a pharmacist-led approach to reduce readmissions. Curr Probl Cardiol. 2019. Al-Bawardy R, et al. Heart failure postdischarge clinic: a pharmacist-led approach to reduce readmissions. Curr Probl Cardiol. 2019.
31.
go back to reference • Bhat S, et al. Outcomes of a pharmacist-managed heart failure medication titration assistance clinic. Ann Pharmacother. 2018;52(8):724–32 Study describes the workflow of a pharmacist-led, protocol-driven, medication titration clinic in a HFrEF, non-veteran population.PubMed • Bhat S, et al. Outcomes of a pharmacist-managed heart failure medication titration assistance clinic. Ann Pharmacother. 2018;52(8):724–32 Study describes the workflow of a pharmacist-led, protocol-driven, medication titration clinic in a HFrEF, non-veteran population.PubMed
32.
go back to reference Donaho EK, Hall AC, Gass JA, Elayda MA, Lee VV, Paire S, et al. Protocol-driven allied health post-discharge transition clinic to reduce hospital readmissions in heart failure. J Am Heart Assoc. 2015;4(12). Donaho EK, Hall AC, Gass JA, Elayda MA, Lee VV, Paire S, et al. Protocol-driven allied health post-discharge transition clinic to reduce hospital readmissions in heart failure. J Am Heart Assoc. 2015;4(12).
33.
go back to reference • Hale GM, et al. Impact of a pharmacist-managed heart failure postdischarge (bridge) clinic for veterans. Ann Pharmacother. 2017;51(7):555–62. Recent large analysis that describes the benefits of medication review, education, and optimization in both HFrEF and HFpEF veterans.PubMed • Hale GM, et al. Impact of a pharmacist-managed heart failure postdischarge (bridge) clinic for veterans. Ann Pharmacother. 2017;51(7):555–62. Recent large analysis that describes the benefits of medication review, education, and optimization in both HFrEF and HFpEF veterans.PubMed
34.
go back to reference Jackevicius CA, de Leon NK, Lu L, Chang DS, Warner AL, Mody FV. Impact of a multidisciplinary heart failure post-hospitalization program on heart failure readmission rates. Ann Pharmacother. 2015;49(11):1189–96.PubMed Jackevicius CA, de Leon NK, Lu L, Chang DS, Warner AL, Mody FV. Impact of a multidisciplinary heart failure post-hospitalization program on heart failure readmission rates. Ann Pharmacother. 2015;49(11):1189–96.PubMed
35.
go back to reference Jain A, Mills P, Nunn LM, Butler J, Luddington L, Ross V, et al. Success of a multidisciplinary heart failure clinic for initiation and up-titration of key therapeutic agents. Eur J Heart Fail. 2005;7(3):405–10.PubMed Jain A, Mills P, Nunn LM, Butler J, Luddington L, Ross V, et al. Success of a multidisciplinary heart failure clinic for initiation and up-titration of key therapeutic agents. Eur J Heart Fail. 2005;7(3):405–10.PubMed
36.
go back to reference Lowrie R, Mair FS, Greenlaw N, Forsyth P, Jhund PS, McConnachie A, et al. Pharmacist intervention in primary care to improve outcomes in patients with left ventricular systolic dysfunction. Eur Heart J. 2012;33(3):314–24.PubMed Lowrie R, Mair FS, Greenlaw N, Forsyth P, Jhund PS, McConnachie A, et al. Pharmacist intervention in primary care to improve outcomes in patients with left ventricular systolic dysfunction. Eur Heart J. 2012;33(3):314–24.PubMed
37.
go back to reference Martinez AS, Saef J, Paszczuk A, Bhatt-Chugani H. Implementation of a pharmacist-managed heart failure medication titration clinic. Am J Health Syst Pharm. 2013;70(12):1070–6.PubMed Martinez AS, Saef J, Paszczuk A, Bhatt-Chugani H. Implementation of a pharmacist-managed heart failure medication titration clinic. Am J Health Syst Pharm. 2013;70(12):1070–6.PubMed
38.
go back to reference Milfred-LaForest SK, Gee JA, Pugacz AM, Piña IL, Hoover DM, Wenzell RC, et al. Heart failure transitions of care: a pharmacist-led post-discharge pilot experience. Prog Cardiovasc Dis. 2017;60(2):249–58.PubMed Milfred-LaForest SK, Gee JA, Pugacz AM, Piña IL, Hoover DM, Wenzell RC, et al. Heart failure transitions of care: a pharmacist-led post-discharge pilot experience. Prog Cardiovasc Dis. 2017;60(2):249–58.PubMed
39.
go back to reference Noschese LA, et al. The pharmacist’s role in medication optimization for patients with chronic heart failure. Fed Pract. 2017;34(Suppl 10):S10–5.PubMedPubMedCentral Noschese LA, et al. The pharmacist’s role in medication optimization for patients with chronic heart failure. Fed Pract. 2017;34(Suppl 10):S10–5.PubMedPubMedCentral
40.
go back to reference Pogge EK, Davis LE. Evaluating the safety and tolerability of sacubitril/valsartan for HFrEF managed within a pharmacist clinic. Am J Cardiovasc Drugs. 2018;18(2):143–51.PubMed Pogge EK, Davis LE. Evaluating the safety and tolerability of sacubitril/valsartan for HFrEF managed within a pharmacist clinic. Am J Cardiovasc Drugs. 2018;18(2):143–51.PubMed
41.
go back to reference Schumacher C, Moaddab G, Colbert M, Kliethermes MA. The effect of clinical pharmacists on readmission rates of heart failure patients in the accountable care environment. J Manag Care Spec Pharm. 2018;24(8):795–9.PubMed Schumacher C, Moaddab G, Colbert M, Kliethermes MA. The effect of clinical pharmacists on readmission rates of heart failure patients in the accountable care environment. J Manag Care Spec Pharm. 2018;24(8):795–9.PubMed
42.
go back to reference Albert NM, Barnason S, Deswal A, Hernandez A, Kociol R, Lee E, et al. Transitions of care in heart failure: a scientific statement from the American Heart Association. Circ Heart Fail. 2015;8(2):384–409.PubMed Albert NM, Barnason S, Deswal A, Hernandez A, Kociol R, Lee E, et al. Transitions of care in heart failure: a scientific statement from the American Heart Association. Circ Heart Fail. 2015;8(2):384–409.PubMed
43.
go back to reference Alexander E, Butler CD, Darr A, Jenkins MT, Long RD, Shipman CJ, et al. ASHP statement on telepharmacy. Am J Health Syst Pharm. 2017;74(9):e236–41.PubMed Alexander E, Butler CD, Darr A, Jenkins MT, Long RD, Shipman CJ, et al. ASHP statement on telepharmacy. Am J Health Syst Pharm. 2017;74(9):e236–41.PubMed
44.
go back to reference Lopez Cabezas C, et al. Randomized clinical trial of a postdischarge pharmaceutical care program vs. regular follow-up in patients with heart failure. Farm Hosp. 2006;30(6):328–42.PubMed Lopez Cabezas C, et al. Randomized clinical trial of a postdischarge pharmaceutical care program vs. regular follow-up in patients with heart failure. Farm Hosp. 2006;30(6):328–42.PubMed
45.
go back to reference McKinley D, Moye-Dickerson P, Davis S, Akil A. Impact of a pharmacist-led intervention on 30-day readmission and assessment of factors predictive of readmission in African American men with heart failure. Am J Mens Health. 2019;13(1):1557988318814295.PubMed McKinley D, Moye-Dickerson P, Davis S, Akil A. Impact of a pharmacist-led intervention on 30-day readmission and assessment of factors predictive of readmission in African American men with heart failure. Am J Mens Health. 2019;13(1):1557988318814295.PubMed
46.
go back to reference Moye PM, Chu PS, Pounds T, Thurston MM. Impact of a pharmacy team-led intervention program on the readmission rate of elderly patients with heart failure. Am J Health Syst Pharm. 2018;75(4):183–90.PubMed Moye PM, Chu PS, Pounds T, Thurston MM. Impact of a pharmacy team-led intervention program on the readmission rate of elderly patients with heart failure. Am J Health Syst Pharm. 2018;75(4):183–90.PubMed
47.
go back to reference Murphy JA, Schroeder MN, Rarus RE, Yakubu I, McKee SOP, Martin SJ. Implementation of a cardiac transitions of care pilot program: a prospective study of inpatient and outpatient clinical pharmacy services for patients with heart failure exacerbation or acute myocardial infarction. J Pharm Pract. 2019;32(1):68–76.PubMed Murphy JA, Schroeder MN, Rarus RE, Yakubu I, McKee SOP, Martin SJ. Implementation of a cardiac transitions of care pilot program: a prospective study of inpatient and outpatient clinical pharmacy services for patients with heart failure exacerbation or acute myocardial infarction. J Pharm Pract. 2019;32(1):68–76.PubMed
48.
go back to reference Rainville EC. Impact of pharmacist interventions on hospital readmissions for heart failure. Am J Health Syst Pharm. 1999;56(13):1339–42.PubMed Rainville EC. Impact of pharmacist interventions on hospital readmissions for heart failure. Am J Health Syst Pharm. 1999;56(13):1339–42.PubMed
49.
go back to reference Salas CM, Miyares MA. Implementing a pharmacy resident run transition of care service for heart failure patients: effect on readmission rates. Am J Health Syst Pharm. 2015;72(11 Suppl 1):S43–7.PubMed Salas CM, Miyares MA. Implementing a pharmacy resident run transition of care service for heart failure patients: effect on readmission rates. Am J Health Syst Pharm. 2015;72(11 Suppl 1):S43–7.PubMed
50.
go back to reference Truong JT, Backes AC. The impact of a continuum of care resident pharmacist on heart failure readmissions and discharge instructions at a community hospital. SAGE Open Med. 2015;3:2050312115577986.PubMedPubMedCentral Truong JT, Backes AC. The impact of a continuum of care resident pharmacist on heart failure readmissions and discharge instructions at a community hospital. SAGE Open Med. 2015;3:2050312115577986.PubMedPubMedCentral
51.
go back to reference Hayhoe B, Verma A, Kumar S. Shared medical appointments. BMJ. 2017;358:j4034.PubMed Hayhoe B, Verma A, Kumar S. Shared medical appointments. BMJ. 2017;358:j4034.PubMed
52.
go back to reference Cohen LB, Taveira TH, Khatana SAM, Dooley AG, Pirraglia PA, Wu WC. Pharmacist-led shared medical appointments for multiple cardiovascular risk reduction in patients with type 2 diabetes. Diabetes Educ. 2011;37(6):801–12.PubMed Cohen LB, Taveira TH, Khatana SAM, Dooley AG, Pirraglia PA, Wu WC. Pharmacist-led shared medical appointments for multiple cardiovascular risk reduction in patients with type 2 diabetes. Diabetes Educ. 2011;37(6):801–12.PubMed
53.
go back to reference Kirsh S, Watts S, Pascuzzi K, O'Day ME, Davidson D, Strauss G, et al. Shared medical appointments based on the chronic care model: a quality improvement project to address the challenges of patients with diabetes with high cardiovascular risk. Qual Saf Health Care. 2007;16(5):349–53.PubMedPubMedCentral Kirsh S, Watts S, Pascuzzi K, O'Day ME, Davidson D, Strauss G, et al. Shared medical appointments based on the chronic care model: a quality improvement project to address the challenges of patients with diabetes with high cardiovascular risk. Qual Saf Health Care. 2007;16(5):349–53.PubMedPubMedCentral
54.
go back to reference Edelman D, et al. In Shared medical appointments for chronic medical conditions: a systematic review. Washington (DC); 2012. Edelman D, et al. In Shared medical appointments for chronic medical conditions: a systematic review. Washington (DC); 2012.
55.
go back to reference Singrey AM, Mehta BH, Casper KA. Management of heart failure patients through integrative medical group visits. Am J Health Syst Pharm. 2015;72(5):349–51.PubMed Singrey AM, Mehta BH, Casper KA. Management of heart failure patients through integrative medical group visits. Am J Health Syst Pharm. 2015;72(5):349–51.PubMed
56.
go back to reference Wu WC, Parent M, Dev S, Hearns R, Taveira TH, Cohen L, et al. Group medical visits after heart failure hospitalization: study protocol for a randomized-controlled trial. Contemp Clin Trials. 2018;71:140–5.PubMed Wu WC, Parent M, Dev S, Hearns R, Taveira TH, Cohen L, et al. Group medical visits after heart failure hospitalization: study protocol for a randomized-controlled trial. Contemp Clin Trials. 2018;71:140–5.PubMed
57.
go back to reference Barker A, Barlis P, Berlowitz D, Page K, Jackson B, Lim WK. Pharmacist directed home medication reviews in patients with chronic heart failure: a randomised clinical trial. Int J Cardiol. 2012;159(2):139–43.PubMed Barker A, Barlis P, Berlowitz D, Page K, Jackson B, Lim WK. Pharmacist directed home medication reviews in patients with chronic heart failure: a randomised clinical trial. Int J Cardiol. 2012;159(2):139–43.PubMed
58.
go back to reference Boykin A, Wright D, Stevens L, Gardner L. Interprofessional care collaboration for patients with heart failure. Am J Health Syst Pharm. 2018;75(1):e45–9.PubMed Boykin A, Wright D, Stevens L, Gardner L. Interprofessional care collaboration for patients with heart failure. Am J Health Syst Pharm. 2018;75(1):e45–9.PubMed
59.
go back to reference Holland R, Brooksby I, Lenaghan E, Ashton K, Hay L, Smith R, et al. Effectiveness of visits from community pharmacists for patients with heart failure: HeartMed randomised controlled trial. BMJ. 2007;334(7603):1098.PubMedPubMedCentral Holland R, Brooksby I, Lenaghan E, Ashton K, Hay L, Smith R, et al. Effectiveness of visits from community pharmacists for patients with heart failure: HeartMed randomised controlled trial. BMJ. 2007;334(7603):1098.PubMedPubMedCentral
60.
go back to reference Kalista T, Lemay V, Cohen L. Postdischarge community pharmacist-provided home services for patients after hospitalization for heart failure. J Am Pharm Assoc (2003). 2015;55(4):438–42. Kalista T, Lemay V, Cohen L. Postdischarge community pharmacist-provided home services for patients after hospitalization for heart failure. J Am Pharm Assoc (2003). 2015;55(4):438–42.
61.
go back to reference Lee VW, Choi LM, Wong WJ, Chung HW, Ng CK, Cheng FW. Pharmacist intervention in the prevention of heart failure for high-risk elderly patients in the community. BMC Cardiovasc Disord. 2015;15:178.PubMedPubMedCentral Lee VW, Choi LM, Wong WJ, Chung HW, Ng CK, Cheng FW. Pharmacist intervention in the prevention of heart failure for high-risk elderly patients in the community. BMC Cardiovasc Disord. 2015;15:178.PubMedPubMedCentral
62.
go back to reference Roughead EE, Barratt JD, Ramsay E, Pratt N, Ryan P, Peck R, et al. The effectiveness of collaborative medicine reviews in delaying time to next hospitalization for patients with heart failure in the practice setting: results of a cohort study. Circ Heart Fail. 2009;2(5):424–8.PubMed Roughead EE, Barratt JD, Ramsay E, Pratt N, Ryan P, Peck R, et al. The effectiveness of collaborative medicine reviews in delaying time to next hospitalization for patients with heart failure in the practice setting: results of a cohort study. Circ Heart Fail. 2009;2(5):424–8.PubMed
63.
go back to reference Stewart S, Pearson S, Horowitz JD. Effects of a home-based intervention among patients with congestive heart failure discharged from acute hospital care. Arch Intern Med. 1998;158(10):1067–72.PubMed Stewart S, Pearson S, Horowitz JD. Effects of a home-based intervention among patients with congestive heart failure discharged from acute hospital care. Arch Intern Med. 1998;158(10):1067–72.PubMed
64.
go back to reference Triller DM, Hamilton RA. Effect of pharmaceutical care services on outcomes for home care patients with heart failure. Am J Health Syst Pharm. 2007;64(21):2244–9.PubMed Triller DM, Hamilton RA. Effect of pharmaceutical care services on outcomes for home care patients with heart failure. Am J Health Syst Pharm. 2007;64(21):2244–9.PubMed
65.
go back to reference Department for Health and Human Services, Centers for Medicare & Medicaid Services. Medicare program; hospital conditions of participation: requirements for approval and reapproval of transplant centers to prefrom organ transplants. Fed Regist. 2007;72(61):15198–280. Department for Health and Human Services, Centers for Medicare & Medicaid Services. Medicare program; hospital conditions of participation: requirements for approval and reapproval of transplant centers to prefrom organ transplants. Fed Regist. 2007;72(61):15198–280.
67.
go back to reference Alloway RR, Dupuis R, Gabardi S, Kaiser TE, Taber DJ, Tichy EM, et al. Evolution of the role of the transplant pharmacist on the multidisciplinary transplant team. Am J Transplant. 2011;11(8):1576–83.PubMed Alloway RR, Dupuis R, Gabardi S, Kaiser TE, Taber DJ, Tichy EM, et al. Evolution of the role of the transplant pharmacist on the multidisciplinary transplant team. Am J Transplant. 2011;11(8):1576–83.PubMed
68.
go back to reference Gellatly RMLC. The addition of a specialist pharmacist to heart transplant and ventricular assist device clinics-early TRANDS in patient care [abstract]. J Heart Lung Transplant. 2015;34:S240–1. Gellatly RMLC. The addition of a specialist pharmacist to heart transplant and ventricular assist device clinics-early TRANDS in patient care [abstract]. J Heart Lung Transplant. 2015;34:S240–1.
69.
go back to reference Thrall SA, Fominaya CE, Chiasson JM, Castle S, Taber DJ. Improvement in immunosuppression therapy monitoring in organ transplant recipients. Am J Health Syst Pharm. 2017;74(17 Supplement 3):S67–74.PubMed Thrall SA, Fominaya CE, Chiasson JM, Castle S, Taber DJ. Improvement in immunosuppression therapy monitoring in organ transplant recipients. Am J Health Syst Pharm. 2017;74(17 Supplement 3):S67–74.PubMed
70.
go back to reference Wang N, Athans V, Neuner E, Bollinger J, Spinner M, Brizendine K. A pharmacist-driven antimicrobial stewardship intervention targeting cytomegalovirus viremia in ambulatory solid organ transplant recipients. Transpl Infect Dis. 2018;20(6):e12991.PubMed Wang N, Athans V, Neuner E, Bollinger J, Spinner M, Brizendine K. A pharmacist-driven antimicrobial stewardship intervention targeting cytomegalovirus viremia in ambulatory solid organ transplant recipients. Transpl Infect Dis. 2018;20(6):e12991.PubMed
71.
go back to reference Bissonnette J, Woodend K, Davies B, Stacey D, Knoll GA. Evaluation of a collaborative chronic care approach to improve outcomes in kidney transplant recipients. Clin Transpl. 2013;27(2):232–8. Bissonnette J, Woodend K, Davies B, Stacey D, Knoll GA. Evaluation of a collaborative chronic care approach to improve outcomes in kidney transplant recipients. Clin Transpl. 2013;27(2):232–8.
72.
go back to reference Cajita MI, Baumgartner E, Berben L, Denhaerynck K, Helmy R, Schönfeld S, et al. Heart transplant centers with multidisciplinary team show a higher level of chronic illness management - findings from the international BRIGHT study. Heart Lung. 2017;46(5):351–6.PubMed Cajita MI, Baumgartner E, Berben L, Denhaerynck K, Helmy R, Schönfeld S, et al. Heart transplant centers with multidisciplinary team show a higher level of chronic illness management - findings from the international BRIGHT study. Heart Lung. 2017;46(5):351–6.PubMed
73.
go back to reference De Geest S, et al. Chronic illness management as an innovative pathway for enhancing long-term survival in transplantation. Am J Transplant. 2011;11(10):2262–3.PubMed De Geest S, et al. Chronic illness management as an innovative pathway for enhancing long-term survival in transplantation. Am J Transplant. 2011;11(10):2262–3.PubMed
74.
go back to reference Bishop MA, Streiff MB, Ensor CR, Tedford RJ, Russell SD, Ross PA. Pharmacist-managed international normalized ratio patient self-testing is associated with increased time in therapeutic range in patients with left ventricular assist devices at an academic medical center. ASAIO J. 2014;60(2):193–8.PubMed Bishop MA, Streiff MB, Ensor CR, Tedford RJ, Russell SD, Ross PA. Pharmacist-managed international normalized ratio patient self-testing is associated with increased time in therapeutic range in patients with left ventricular assist devices at an academic medical center. ASAIO J. 2014;60(2):193–8.PubMed
75.
go back to reference Kuyumjian YM, Miyares MA, Leverock J, Chaparro S, Baker WL, Jennings DL. A multidisciplinary team-based process improves outpatient anticoagulation quality with continuous-flow left-ventricular assist devices. Int J Cardiol. 2016;218:118–9.PubMed Kuyumjian YM, Miyares MA, Leverock J, Chaparro S, Baker WL, Jennings DL. A multidisciplinary team-based process improves outpatient anticoagulation quality with continuous-flow left-ventricular assist devices. Int J Cardiol. 2016;218:118–9.PubMed
76.
go back to reference Borden M, Kiernan MS, Pham DT, DeNofrio D, Sylvia L. Bridging with half-therapeutic dose enoxaparin in outpatients with left ventricular assist devices and sub-therapeutic international normalized ratios. J Heart Lung Transplant. 2015;34(6):860–2.PubMed Borden M, Kiernan MS, Pham DT, DeNofrio D, Sylvia L. Bridging with half-therapeutic dose enoxaparin in outpatients with left ventricular assist devices and sub-therapeutic international normalized ratios. J Heart Lung Transplant. 2015;34(6):860–2.PubMed
77.
go back to reference American Pharmacists Association, F. and A. American Pharmacists. Consortium recommendations for advancing pharmacists’ patient care services and collaborative practice agreements. J Am Pharm Assoc (2003). 2013;53(2):e132–41. American Pharmacists Association, F. and A. American Pharmacists. Consortium recommendations for advancing pharmacists’ patient care services and collaborative practice agreements. J Am Pharm Assoc (2003). 2013;53(2):e132–41.
78.
go back to reference •• Centers for Disease Control and Prevention. Advancing team-based care through collaborative practice agreement: a resource and implementation guide for adding pharmacists to the care team. Atlanta: Centers for Disease Control and Prevention, U.S. Department fo Health and Human Services; 2017. This guide provides an outline of the steps needed to incorporate pharmacists into the ambulatory care setting through the use of collaborative practice agreements. •• Centers for Disease Control and Prevention. Advancing team-based care through collaborative practice agreement: a resource and implementation guide for adding pharmacists to the care team. Atlanta: Centers for Disease Control and Prevention, U.S. Department fo Health and Human Services; 2017. This guide provides an outline of the steps needed to incorporate pharmacists into the ambulatory care setting through the use of collaborative practice agreements.
79.
go back to reference Hazlet TK, Karwaki TE, Downing DF. Pathway to pharmacist medical provider status in Washington State. J Am Pharm Assoc (2003). 2017;57(1):116–9. Hazlet TK, Karwaki TE, Downing DF. Pathway to pharmacist medical provider status in Washington State. J Am Pharm Assoc (2003). 2017;57(1):116–9.
80.
go back to reference Hawes EM, Misita C, Burkhart JI, McKnight L, Deyo ZM, Lee RA, et al. Prescribing pharmacists in the ambulatory care setting: experience at the University of North Carolina Medical Center. Am J Health Syst Pharm. 2016;73(18):1425–33.PubMed Hawes EM, Misita C, Burkhart JI, McKnight L, Deyo ZM, Lee RA, et al. Prescribing pharmacists in the ambulatory care setting: experience at the University of North Carolina Medical Center. Am J Health Syst Pharm. 2016;73(18):1425–33.PubMed
81.
go back to reference Maldonado AQ, Seiger TC, Urann CL, McCleary JA, Goroski AL, Ojogho ON. Billing for outpatient transplant pharmacy services. Am J Health Syst Pharm. 2012;69(2):144–7.PubMed Maldonado AQ, Seiger TC, Urann CL, McCleary JA, Goroski AL, Ojogho ON. Billing for outpatient transplant pharmacy services. Am J Health Syst Pharm. 2012;69(2):144–7.PubMed
82.
go back to reference Department for Health and Human Services, Centers for Medicare & Medicaid Services. Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs; Organ Procurement Organization Reporting and Communication; Transplant Outcome Measures and Documentation Requirements; Electronic Health Record (EHR) Incentive Programs; Payment to Nonexcepted Off-Campus ProviderBased Department of a Hospital; Hospital Value-Based Purchasing (VBP) Program; Establishment of payment rates under the medicare physician fee schedule for nonexcepted items and services furnished by an off-campus provider-based Department of a Hospital Federal Register. 2016;81(219):79562–79892. Department for Health and Human Services, Centers for Medicare & Medicaid Services. Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs; Organ Procurement Organization Reporting and Communication; Transplant Outcome Measures and Documentation Requirements; Electronic Health Record (EHR) Incentive Programs; Payment to Nonexcepted Off-Campus ProviderBased Department of a Hospital; Hospital Value-Based Purchasing (VBP) Program; Establishment of payment rates under the medicare physician fee schedule for nonexcepted items and services furnished by an off-campus provider-based Department of a Hospital Federal Register. 2016;81(219):79562–79892.
83.
go back to reference Sachdev GP. Billing for pharmacists’ services provided to ambulatory care patients. Am J Health Syst Pharm. 2012;69(2):105.PubMed Sachdev GP. Billing for pharmacists’ services provided to ambulatory care patients. Am J Health Syst Pharm. 2012;69(2):105.PubMed
Metadata
Title
The Impact of Pharmacist-Based Services Across the Spectrum of Outpatient Heart Failure Therapy
Authors
Lucianne M. West, PharmD, BCCP
J. Bradley Williams, PharmD, BCPS
Kathleen D. Faulkenberg, PharmD, BCPS
Publication date
01-10-2019
Publisher
Springer US
Keyword
Heart Failure
Published in
Current Treatment Options in Cardiovascular Medicine / Issue 10/2019
Print ISSN: 1092-8464
Electronic ISSN: 1534-3189
DOI
https://doi.org/10.1007/s11936-019-0750-3

Other articles of this Issue 10/2019

Current Treatment Options in Cardiovascular Medicine 10/2019 Go to the issue

Arrhythmia (R Kabra, Section Editor)

Leadless Pacemakers: Recent and Future Developments